Sexual health

Why Bacterial Vaginosis Keeps Returning

Save

Recurrent bacterial vaginosis is common enough that many people assume something is wrong with the treatment, or with them. Neither is quite right. BV isn't classified as a sexually transmitted infection, but the disrupted vaginal microbiome that caused it the first time is often still there after antibiotics clear the symptoms — which is why the same discharge and odor can return within weeks or months.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Continue in Claude

Open a chat with this article’s link already in the message, and keep asking questions there. Claude reads the article and its sources; nothing about you is included.

Continue in Claude →

The button opens the Claude desktop app and fills in the message for you to review before sending. No desktop app, or reading on a phone? Copy the prompt and paste it into any AI.

Why does bacterial vaginosis keep coming back?

Bacterial vaginosis happens when the vagina's normally protective bacteria — mostly different Lactobacillus species — are outnumbered by a mix of other bacteria that cause no problem in small numbers but do in large ones. Standard treatment kills off that overgrowth and resolves the discharge, odor, and irritation, but it doesn't automatically restore the Lactobacillus-dominant environment that kept those other bacteria in check. Until that balance rebuilds on its own, the same overgrowth has room to happen again. A recurrence doesn't mean the first treatment failed or that something is wrong with you.

Some of the bacteria involved are also thought to persist in a thin, sticky layer — a biofilm — coating the vaginal wall even after a course of treatment clears enough of them to resolve symptoms. A biofilm is harder for antibiotics to fully penetrate than free-floating bacteria, which is one reason a second or third episode can follow a first one that seemed to clear completely. It's closer to how a garden that's been weeded still needs its soil rebuilt, or the same weeds return.

How BV is actually diagnosed

BV is generally diagnosed with a pelvic exam and a sample of vaginal discharge, not from symptoms alone, because the odor and discharge changes it causes overlap with other conditions. A clinician typically looks at the sample under a microscope for "clue cells" — vaginal cells coated in bacteria that give them a stippled appearance — checks the vaginal pH, and notes whether a distinct odor develops when a specific reagent is added to the sample. Some clinics also send the sample for a lab test that identifies the bacteria more precisely.

Self-diagnosing a recurrence from symptoms alone, especially after a first confirmed episode, is one of the more common reasons treatment doesn't work the second or third time. The symptoms feel familiar, so the same over-the-counter or leftover prescription treatment gets reused — but the actual cause this time might be a yeast infection, trichomoniasis, or a mixed infection that needs a different approach entirely.

Is bacterial vaginosis a sexually transmitted infection?

Bacterial vaginosis is not classified as a sexually transmitted infection, and national screening guidance reflects that distinction: recommended routine STI screening focuses on chlamydia, gonorrhea, syphilis, HIV, and hepatitis, not on bacterial vaginosis 1. That doesn't mean sexual activity is irrelevant — BV is more common in people who are sexually active, and new or multiple partners are associated with higher risk — only that BV doesn't behave like a classic STI with a single identifiable pathogen passed between partners.

That distinction also separates BV from a newer prevention strategy some readers may have heard of: doxycycline post-exposure prophylaxis, or doxy-PEP, is a preventive antibiotic dose recommended specifically for people at risk of chlamydia, gonorrhea, or syphilis after condomless sex — a defined set of bacterial STIs that BV isn't part of 2. There's no equivalent prevention regimen for BV, because the underlying problem isn't a single sexually transmitted organism to block.

Telling BV apart from a yeast infection or trichomoniasis

Recurring symptoms don't always mean recurring BV. A thin, gray-white discharge with a distinct fishy odor, especially noticeable after sex, points toward BV, while thick, white, cottage-cheese-like discharge with itching more often points toward a yeast infection, and a frothy, yellow-green discharge with irritation points toward trichomoniasis. Telling BV apart from a yeast infection and trichomoniasis matters because the treatments are different, and treating the wrong one does nothing for symptoms that will keep returning regardless.

Learning what your discharge is telling you — color, texture, smell, and timing — is a faster way to narrow down the possibilities than guessing from memory of a past episode. This is also why recurring yeast infections after sex sometimes get mistaken for recurrent BV, or the reverse: both can flare around similar triggers, including sex itself, and both can occur at the same time. A discharge that looks or smells different from a prior BV episode is a reasonable signal to get re-tested rather than retreat with whatever worked last time.

What to do when BV keeps recurring

Two or more episodes within about six months to a year is generally what clinicians consider recurrent, and it's a reason to get re-examined rather than repeat the same treatment that worked the first time. The same principle applies to other genital infections that don't resolve as expected: when symptoms persist or return after treatment, guidelines for those infections direct clinicians toward confirming the diagnosis again rather than assuming the original treatment simply needs repeating 3. A clinician can also check for a coexisting infection, since BV and trichomoniasis in particular can occur together.

For genuinely recurrent, confirmed BV, clinicians have options beyond a single short course of treatment, including a longer or repeated course, or a different medication than was used the first time. What's right depends on how many episodes someone has had, what's already been tried, and whether the exam turns up anything else worth treating at the same time — which is why recurrent BV is a conversation with a clinician rather than a repeat trip to the same treatment.

Does a partner need treatment too?

For a partner with a vagina, some clinicians consider treating both partners together when BV keeps recurring, on the theory that an unresolved imbalance in one partner's flora can reintroduce the same bacteria after treatment. Partner treatment for BV isn't standardized the way it is for classic bacterial STIs: for chlamydia and gonorrhea, guidelines direct clinicians to routinely offer treatment to a patient's recent partners specifically because a single, identifiable organism passes back and forth between people 4. BV doesn't have that same single-organism structure.

Whether treating a partner helps with BV specifically is an active, evolving question, and practice varies by clinician — worth raising directly at a follow-up visit rather than assuming one way or the other. Either way, a partner with symptoms of their own, of any kind, is worth having evaluated rather than ignored.

Common questions

There's no single universal cutoff, but many clinicians use two or more episodes within six months, or three or more within a year, as the point where it's worth a closer look rather than repeating the same treatment again. If episodes are close enough together that one seems to blend into the next, that's also worth flagging even before hitting a specific count.

Sometimes mild BV symptoms fade without treatment, but there's no reliable way to predict who that will happen for, and symptoms fading doesn't necessarily mean the underlying bacterial imbalance has corrected itself — which is part of why it can return. Getting a proper diagnosis, rather than waiting it out, is the more reliable way to know what's actually going on.

No — douching disrupts the vagina's protective bacteria further and is generally discouraged rather than recommended as a way to manage or prevent BV. The vagina doesn't need internal cleaning to stay healthy, and that kind of disruption is part of what tips the balance toward BV overgrowth in the first place.

It can be shared between partners with vaginas more directly than it typically passes to a male partner, because it involves an imbalance of vaginal bacteria rather than a single organism specific to one anatomy. That's part of why some clinicians recommend evaluating both partners in a relationship between two women when BV keeps recurring, even though BV itself isn't classified as an STI.

For many people, yes — episodes often become less frequent over time, especially once a trigger like a new medication, a new partner, or a particular contraceptive method is identified and addressed. For others, recurrence continues until it's specifically treated as a recurrent condition rather than one isolated infection after another, which usually means a different treatment approach and closer follow-up.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When recurring symptoms need more than another round of the same treatment

  • —Pelvic pain or fever along with discharge, which can point to a different or more serious infection
  • —Discharge, odor, or bleeding that doesn't match a prior confirmed BV episode
  • —Any BV-like symptoms during pregnancy
  • —Symptoms that return within days to weeks of finishing treatment, rather than weeks to months later

Fever or pelvic pain alongside discharge can signal a different or more serious infection, such as pelvic inflammatory disease, and warrants same-day evaluation in urgent care or an emergency department rather than a routine appointment.

This article is educational and doesn't replace an in-person exam; only testing can confirm bacterial vaginosis and rule out other causes of similar symptoms.

References

  1. 1.Centers for Disease Control and Prevention (2021). STI Screening Recommendations. CDC STI Treatment Guidelines, 2021. linkSupports that CDC's routine STI screening recommendations focus on chlamydia, gonorrhea, syphilis, HIV, and hepatitis, used here to establish that BV is not part of that routine STI screening framework.
  2. 2.Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024). CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024. MMWR Recommendations and Reports, Vol. 73, No. 2. doi:10.15585/mmwr.rr7302a1 ✓Supports that doxy-PEP is recommended specifically for preventing chlamydia, gonorrhea, or syphilis after condomless sex in an eligible population, used to establish that BV falls outside the specific bacterial STIs this prevention strategy targets.
  3. 3.Centers for Disease Control and Prevention (2021). Mycoplasma genitalium - STI Treatment Guidelines. CDC STI Treatment Guidelines, 2021. linkSupports that guidelines for a persistent or recurring genital infection (M. genitalium) direct clinicians to reconfirm the diagnosis and adjust the approach after treatment doesn't resolve symptoms, used here as an analogous, guideline-based principle for recurring genital symptoms in general.
  4. 4.Centers for Disease Control and Prevention (2021). Expedited Partner Therapy. CDC STI Treatment Guidelines, 2021. linkSupports that providers routinely offer expedited partner therapy for chlamydia and gonorrhea because a single identifiable organism passes between partners, used here to contrast with BV, which lacks that single-organism structure and standardized partner-treatment protocol.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library